← Leaderboards
Benjamin E Deverman
Broad Institute, Inc.
$18,180,267
Attributed
$35,999,088
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $12.2M · FY2018–25$20M$15M$10M$5M$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$36,999,088 · 9
By mechanism
UF1$10,679,255 · 1
UG3$9,198,118 · 2
UH3$7,346,370 · 2
U19$6,000,331 · 2
U01$3,335,014 · 1
R21$440,000 · 1
Top collaborators
- Gordon J Fishell6 shared
- Yating Wang4 shared
- Jordane Dimidschstein2 shared
- Guoping Feng2 shared
- Evan Z Macosko2 shared
- Paola Arlotta1 shared
- Sonia Minikel Vallabh1 shared
Most similar at Broad Institute, Inc.
Same institution · by research overlap
- Eric Vallabh Minikel$8,891,123
- Sonia Minikel Vallabh$10,218,926
- Paul Clark Blainey$19,793,618
- David R Liu$34,362,066
- Xiao Wang$5,402,079
Others in their field
Other Emerging Leaders on “Capsid”
- Arnab Kumar Chatterjee · Washington University$22,541,385
- Leonard Freedman · Leidos Biomedical Research, Inc.$6,934,050
- Matthew R Vogt · Univ Of North Carolina Chapel Hill$5,421,688
- Yating Wang · Broad Institute, Inc.$4,966,476
- Patrick R Secor · University Of Montana$4,394,600
- William Raymond Lagor · Baylor College Of Medicine$4,287,807
Research focus
CapsidEngineeringIn VivoCellsGenesCell TypeBrainCallithrixGene ExpressionInjectionsNeuronsCollaborationsVectorAnimalsTechnologyNonhuman PrimateDependovirusVirusAdeno-Associated Viral VectorSafetySuccessBlood - Brain Barrier AnatomyTransgene ExpressionMental Disorders
Grant awards (19)
BRAIN CONNECTS: High-Throughput Single Cell Projection Mapping and Spine Quantification in the Primate Brain by Synaptic Barcoding$1,853,811
U01 · FY2025 · NS
Research Core (Deverman)$1,520,416
U19 · FY2025 · NS · contact PI
Therapeutic Editing to Lower PrP in Prion Disease$1,000,000
U19 · FY2025 · NS
Development and validation of AAV vectors to manipulate specific neuronal subtypes and circuits involved in epilepsy and psychiatric disorders across mammalian species.$2,252,723
UH3 · FY2024 · MH
Research Core (Deverman)$2,188,795
U19 · FY2024 · NS · contact PI
BRAIN CONNECTS: High-Throughput Single Cell Projection Mapping and Spine Quantification in the Primate Brain by Synaptic Barcoding$1,481,203
U01 · FY2024 · NS
Development and validation of AAV vectors to manipulate specific neuronal subtypes and circuits involved in epilepsy and psychiatric disorders across mammalian species.$2,428,662
UH3 · FY2023 · MH
Research Core (Deverman)$1,291,120
U19 · FY2023 · NS · contact PI
Systematic identification of enhancers to target the breadth of excitatory and inhibitory neuronal cell types in the cerebral cortex$10,679,255
UF1 · FY2022 · MH
Novel AAVs Engineered for Efficient and Noninvasive Cross-Species Gene Editing Throughout the Central Nervous System$1,359,680
UH3 · FY2022 · NS · contact PI
Novel AAV Capsids and Gene Regulatory Elements for GeneExpression in Microglia$200,000
R21 · FY2022 · MH · contact PI
Development and validation of AAV vectors to manipulate specific neuronal subtypes and circuits involved in epilepsy and psychiatric disorders across mammalian species.$2,208,603
UG3 · FY2021 · MH
Novel AAVs engineered for efficient and noninvasive cross-species gene editing throughout the central nervous system$1,305,305
UH3 · FY2021 · NS · contact PI
Novel AAV Capsids and Gene Regulatory Elements for GeneExpression in Microglia$240,000
R21 · FY2021 · MH · contact PI
Development and validation of AAV vectors to manipulate specific neuronal subtypes and circuits involved in epilepsy and psychiatric disorders across mammalian species.$2,240,361
UG3 · FY2020 · MH
Novel AAVs engineered for efficient and noninvasive cross-species gene editing throughout the central nervous system$819,283
UG3 · FY2020 · NS · contact PI
Development and validation of AAV vectors to manipulate specific neuronal subtypes and circuits involved in epilepsy and psychiatric disorders across mammalian species.$2,248,706
UG3 · FY2019 · MH
Novel AAVs engineered for efficient and noninvasive cross-species gene editing throughout the central nervous system$834,904
UG3 · FY2019 · NS · contact PI
Novel AAVs engineered for efficient and noninvasive cross-species gene editing throughout the central nervous system$846,261
UG3 · FY2018 · NS · contact PI